List Name |
Annotation |
Enrichment |
p-value |
spinal cord development |
AmiGO Browser |
28.90 |
2.14e-03 |
eye photoreceptor cell differentiation |
AmiGO Browser |
21.29 |
3.95e-03 |
eye photoreceptor cell development |
AmiGO Browser |
21.29 |
3.95e-03 |
photoreceptor cell development |
AmiGO Browser |
20.23 |
4.38e-03 |
photoreceptor cell differentiation |
AmiGO Browser |
20.23 |
4.38e-03 |
response to metal ion |
AmiGO Browser |
19.26 |
4.82e-03 |
negative regulation of signal transduction |
AmiGO Browser |
5.39 |
6.84e-03 |
response to inorganic substance |
AmiGO Browser |
14.98 |
7.90e-03 |
eye morphogenesis |
AmiGO Browser |
12.26 |
0.01 |
sensory organ development |
AmiGO Browser |
6.01 |
0.01 |
positive regulation of transcription factor activity |
AmiGO Browser |
10.65 |
0.02 |
keratinocyte differentiation |
AmiGO Browser |
10.11 |
0.02 |
lymphocyte mediated immunity |
AmiGO Browser |
5.23 |
0.02 |
regulation of signal transduction |
AmiGO Browser |
2.37 |
0.02 |
cellular morphogenesis during differentiation |
AmiGO Browser |
3.78 |
0.02 |
enzyme linked receptor protein signaling pathway |
AmiGO Browser |
2.77 |
0.02 |
eye development |
AmiGO Browser |
8.43 |
0.02 |
leukocyte mediated immunity |
AmiGO Browser |
4.89 |
0.02 |
small GTPase mediated signal transduction |
AmiGO Browser |
2.42 |
0.03 |
MAPKKK cascade |
AmiGO Browser |
3.53 |
0.03 |
erythrocyte differentiation |
AmiGO Browser |
7.49 |
0.03 |
phosphate metabolic process |
AmiGO Browser |
1.87 |
0.03 |
phosphorus metabolic process |
AmiGO Browser |
1.87 |
0.03 |
glial cell differentiation |
AmiGO Browser |
7.22 |
0.03 |
B cell differentiation |
AmiGO Browser |
7.10 |
0.03 |
immune effector process |
AmiGO Browser |
4.24 |
0.03 |
gliogenesis |
AmiGO Browser |
6.86 |
0.03 |
regulation of Ras GTPase activity |
AmiGO Browser |
6.63 |
0.04 |
positive regulation of binding |
AmiGO Browser |
25.28 |
0.04 |
positive regulation of small GTPase mediated signal transduction |
AmiGO Browser |
25.28 |
0.04 |
positive regulation of interferon-gamma biosynthetic process |
AmiGO Browser |
25.28 |
0.04 |
regulation of transcription factor activity |
AmiGO Browser |
6.42 |
0.04 |
protein amino acid phosphorylation |
AmiGO Browser |
2.00 |
0.04 |
regionalization |
AmiGO Browser |
3.97 |
0.04 |
regulation of small GTPase mediated signal transduction |
AmiGO Browser |
3.11 |
0.04 |
regulation of Rho GTPase activity |
AmiGO Browser |
22.47 |
0.04 |
ribonucleotide catabolic process |
AmiGO Browser |
22.47 |
0.04 |
liver development |
AmiGO Browser |
22.47 |
0.04 |
negative regulation of BMP signaling pathway |
AmiGO Browser |
22.47 |
0.04 |
negative regulation of small GTPase mediated signal transduction |
AmiGO Browser |
22.47 |
0.04 |
lung development |
AmiGO Browser |
6.04 |
0.04 |
regulation of apoptosis |
AmiGO Browser |
2.06 |
0.04 |
regulation of programmed cell death |
AmiGO Browser |
2.04 |
0.05 |
endocytosis |
AmiGO Browser |
2.97 |
0.05 |
membrane invagination |
AmiGO Browser |
2.97 |
0.05 |
respiratory tube development |
AmiGO Browser |
5.78 |
0.05 |
membrane organization and biogenesis |
AmiGO Browser |
2.57 |
0.05 |
positive regulation of B cell proliferation |
AmiGO Browser |
20.23 |
0.05 |
regulation of BMP signaling pathway |
AmiGO Browser |
20.23 |
0.05 |
peptidyl-histidine modification |
AmiGO Browser |
20.23 |
0.05 |
receptor-mediated endocytosis |
AmiGO Browser |
5.62 |
0.05 |
cell morphogenesis |
AmiGO Browser |
2.12 |
0.05 |
cellular structure morphogenesis |
AmiGO Browser |
2.12 |
0.05 |
induction of apoptosis by extracellular signals |
AmiGO Browser |
5.54 |
0.05 |
zinc ion transport |
AmiGO Browser |
18.39 |
0.05 |
regulation of DNA repair |
AmiGO Browser |
18.39 |
0.05 |
negative regulation of cell-cell adhesion |
AmiGO Browser |
18.39 |
0.05 |
digestive tract morphogenesis |
AmiGO Browser |
18.39 |
0.05 |
male sex determination |
AmiGO Browser |
18.39 |
0.05 |
negative regulation of B cell activation |
AmiGO Browser |
18.39 |
0.05 |
folic acid transport |
AmiGO Browser |
16.86 |
0.06 |
regulation of cell-matrix adhesion |
AmiGO Browser |
16.86 |
0.06 |
nucleosome disassembly |
AmiGO Browser |
16.86 |
0.06 |
synaptic vesicle exocytosis |
AmiGO Browser |
16.86 |
0.06 |
regulation of interferon-gamma biosynthetic process |
AmiGO Browser |
16.86 |
0.06 |
chromatin disassembly |
AmiGO Browser |
16.86 |
0.06 |
immunoglobulin mediated immune response |
AmiGO Browser |
5.12 |
0.06 |
B cell mediated immunity |
AmiGO Browser |
5.12 |
0.06 |
gland development |
AmiGO Browser |
4.99 |
0.06 |
embryonic organ morphogenesis |
AmiGO Browser |
15.56 |
0.06 |
regulation of cell-cell adhesion |
AmiGO Browser |
15.56 |
0.06 |
interferon-gamma biosynthetic process |
AmiGO Browser |
15.56 |
0.06 |
regulation of T-helper cell differentiation |
AmiGO Browser |
15.56 |
0.06 |
brain development |
AmiGO Browser |
3.32 |
0.06 |
organ morphogenesis |
AmiGO Browser |
2.13 |
0.07 |
transmembrane receptor protein tyrosine kinase signaling pathway |
AmiGO Browser |
2.64 |
0.07 |
positive regulation of DNA metabolic process |
AmiGO Browser |
14.45 |
0.07 |
protein heterooligomerization |
AmiGO Browser |
14.45 |
0.07 |
regulation of production of molecular mediator of immune response |
AmiGO Browser |
14.45 |
0.07 |
cytokine production during immune response |
AmiGO Browser |
14.45 |
0.07 |
regulation of cytokine production during immune response |
AmiGO Browser |
14.45 |
0.07 |
thyroid hormone metabolic process |
AmiGO Browser |
14.45 |
0.07 |
protein modification process |
AmiGO Browser |
1.51 |
0.07 |
cofactor transport |
AmiGO Browser |
12.64 |
0.08 |
regulation of chemotaxis |
AmiGO Browser |
12.64 |
0.08 |
regulation of B cell proliferation |
AmiGO Browser |
12.64 |
0.08 |
response to oxidative stress |
AmiGO Browser |
4.40 |
0.08 |
post-translational protein modification |
AmiGO Browser |
1.54 |
0.08 |
regulation of Ras protein signal transduction |
AmiGO Browser |
3.00 |
0.08 |
protein amino acid dephosphorylation |
AmiGO Browser |
2.99 |
0.08 |
L-fucose catabolic process |
AmiGO Browser |
11.90 |
0.08 |
fucose catabolic process |
AmiGO Browser |
11.90 |
0.08 |
alpha-beta T cell differentiation during immune response |
AmiGO Browser |
11.90 |
0.08 |
specification of organ identity |
AmiGO Browser |
11.90 |
0.08 |
cell-cell signaling during cell fate commitment |
AmiGO Browser |
11.90 |
0.08 |
negative regulation of endothelial cell proliferation |
AmiGO Browser |
11.90 |
0.08 |
induction of an organ |
AmiGO Browser |
11.90 |
0.08 |
induction |
AmiGO Browser |
11.90 |
0.08 |
T cell activation during immune response |
AmiGO Browser |
11.90 |
0.08 |
negative regulation of transcription factor activity |
AmiGO Browser |
11.90 |
0.08 |
CD4-positive, alpha-beta T cell differentiation during immune response |
AmiGO Browser |
11.90 |
0.08 |
leukocyte activation during immune response |
AmiGO Browser |
11.90 |
0.08 |
lymphocyte activation during immune response |
AmiGO Browser |
11.90 |
0.08 |
cell activation during immune response |
AmiGO Browser |
11.90 |
0.08 |
T cell differentiation during immune response |
AmiGO Browser |
11.90 |
0.08 |
T-helper cell differentiation |
AmiGO Browser |
11.90 |
0.08 |
regulation of bone mineralization |
AmiGO Browser |
11.90 |
0.08 |
response to chemical stimulus |
AmiGO Browser |
2.01 |
0.08 |
cell development |
AmiGO Browser |
1.55 |
0.08 |
phosphorylation |
AmiGO Browser |
1.72 |
0.08 |
innate immune response |
AmiGO Browser |
4.17 |
0.08 |
central nervous system development |
AmiGO Browser |
2.44 |
0.08 |
adrenal gland development |
AmiGO Browser |
11.24 |
0.09 |
regulation of DNA binding |
AmiGO Browser |
11.24 |
0.09 |
natural killer cell mediated cytotoxicity |
AmiGO Browser |
11.24 |
0.09 |
natural killer cell mediated immunity |
AmiGO Browser |
11.24 |
0.09 |
vitamin transport |
AmiGO Browser |
11.24 |
0.09 |
regulation of isotype switching |
AmiGO Browser |
11.24 |
0.09 |
biopolymer modification |
AmiGO Browser |
1.47 |
0.09 |
regulation of exocytosis |
AmiGO Browser |
10.65 |
0.09 |
dicarboxylic acid transport |
AmiGO Browser |
10.65 |
0.09 |
CD4-positive, alpha beta T cell differentiation |
AmiGO Browser |
10.65 |
0.09 |
neutral amino acid transport |
AmiGO Browser |
10.65 |
0.09 |
induction of apoptosis |
AmiGO Browser |
2.37 |
0.09 |
induction of programmed cell death |
AmiGO Browser |
2.36 |
0.09 |
negative regulation of apoptosis |
AmiGO Browser |
2.35 |
0.09 |
regulation of cell motility |
AmiGO Browser |
3.89 |
0.09 |
transmembrane receptor protein serine/threonine kinase signaling pathway |
AmiGO Browser |
3.89 |
0.09 |
negative regulation of immune response |
AmiGO Browser |
10.11 |
0.09 |
positive regulation of anti-apoptosis |
AmiGO Browser |
10.11 |
0.09 |
purine nucleoside monophosphate metabolic process |
AmiGO Browser |
10.11 |
0.09 |
purine nucleoside monophosphate biosynthetic process |
AmiGO Browser |
10.11 |
0.09 |
negative regulation of immune system process |
AmiGO Browser |
10.11 |
0.09 |
T-helper 2 type immune response |
AmiGO Browser |
10.11 |
0.09 |
purine ribonucleoside monophosphate metabolic process |
AmiGO Browser |
10.11 |
0.09 |
interferon-gamma production |
AmiGO Browser |
10.11 |
0.09 |
regulation of immune effector process |
AmiGO Browser |
10.11 |
0.09 |
purine ribonucleoside monophosphate biosynthetic process |
AmiGO Browser |
10.11 |
0.09 |
organ development |
AmiGO Browser |
1.52 |
0.09 |
pattern specification process |
AmiGO Browser |
2.78 |
0.09 |
negative regulation of programmed cell death |
AmiGO Browser |
2.33 |
0.10 |
regulation of transforming growth factor beta receptor signaling pathway |
AmiGO Browser |
9.63 |
0.10 |
leukocyte mediated cytotoxicity |
AmiGO Browser |
9.63 |
0.10 |
L-fucose metabolic process |
AmiGO Browser |
9.63 |
0.10 |
response to pain |
AmiGO Browser |
9.63 |
0.10 |
phospholipid transport |
AmiGO Browser |
9.63 |
0.10 |
regulation of locomotion |
AmiGO Browser |
3.75 |
0.10 |
nucleotide catabolic process |
AmiGO Browser |
9.19 |
0.10 |
dephosphorylation |
AmiGO Browser |
2.66 |
0.10 |
regulation of Rho protein signal transduction |
AmiGO Browser |
3.64 |
0.10 |